News
ASCO: New hope for immunotherapy in advanced ovarian cancer
- Author:
- Patrice Wendlng
Publish date: June 9, 2015
Key clinical point: The monoclonal antibodies avelumab and pembrolizumab produced good antitumor activity in patients with advanced ovarian cancer...